Review
Pathology
Lin Yuan, Tsung-Teh Wu, Lizhi Zhang
Summary: Microscopic colitis (MC) is a chronic inflammatory disease of the colon characterized by chronic, watery, nonbloody diarrhea and normal or almost normal endoscopic findings. Two main subtypes of MC, lymphocytic colitis (LC) and collagenous colitis (CC), are identified through microscopic examination on colon biopsy. The pathogenesis of MC is still unclear, but it has been associated with various risk factors and other diseases such as celiac disease, inflammatory bowel disease, and medication use. This paper aims to provide a systematic introduction to the clinicopathologic features of MC, focusing on unusual features and associations with other conditions.
Article
Gastroenterology & Hepatology
Johanna Kristina Larsson, Spencer Clarkson, Klas Sjoberg
Summary: The incidence of microscopic colitis (MC) has been increasing in the southern region of Sweden over the past decades. This study aimed to determine the incidence of lymphocytic colitis (LC) and collagenous colitis (CC) in the county of Skane during the period of 2010-2020, with a focus on temporal and spatial variations. The diagnosis of MC was retrieved from biopsy registries, and established diagnostic criteria were used. The study identified 1985 patients, with stable incidence of CC and a significant increase in the incidence of LC, particularly in the northwest region of Skane.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
(2023)
Article
Gastroenterology & Hepatology
Hamed Khalili, Jordan E. Axelrad, Bjorn Roelstraete, Ola Olen, Mauro D'Amato, Jonas F. Ludvigsson
Summary: The study reveals that gastrointestinal infections are associated with an increased risk of microscopic colitis, especially Clostridioides difficile. The association between gastrointestinal infections and risk of MC is stronger for the collagenous subtype.
Review
Medicine, General & Internal
Emese Mihaly, Arpad Patai, Zsolt Tulassay
Summary: Microscopic colitis (MC) is increasingly recognized, but there are still many unanswered questions regarding its pathogenesis, diagnosis, and therapy. The relationship between microbiome changes, different subtypes of the disease, and the effectiveness of treatments like budesonide and biologics remain unclear, highlighting the need for further research in the future.
FRONTIERS IN MEDICINE
(2021)
Article
Pathology
Peter Johan Heiberg Engel, Anne-Marie Kanstrup Fiehn, Danny Goudkade, Jeppe Thagaard, Henrik Holten-Rossing, Stefania Landolfi, Vincenzo Villanacci, Lars Kristian Munck
Summary: Microscopic colitis (MC) encompasses lymphocytic colitis (LC) and collagenous colitis (CC). LC often presents with thickening of the subepithelial collagen band, while CC is characterized by an increased number of intraepithelial T-lymphocytes (IELs). The essential histopathological feature of MC is considered to be the lymphocytic inflammatory infiltration of the mucosa, although there is a non-linear correlation between the number of IELs and thickness of the collagenous band, indicating differences in their pathogenesis.
ANNALS OF DIAGNOSTIC PATHOLOGY
(2021)
Article
Medicine, Research & Experimental
Sergio Lopez-Estevez, Georgia Gris, Beatriz de la Puente, Alicia Carceller, Vicente Martinez
Summary: Sigma-1 receptors play an important role in intestinal inflammation-associated referred hyperalgesia, with knockout mice showing significant attenuation in inflammation associated hypersensitivity. The absence of sigma(1)Rs had little impact on colitis generation and progression, but did show reduction in edema and down-regulation of iNOS gene expression during the chronic phase.
BIOMEDICINE & PHARMACOTHERAPY
(2021)
Article
Gastroenterology & Hepatology
Samuel W. Chey, Maria Westerhoff, William D. Chey
Summary: This is the first scientific report to describe lymphocytic colitis as a potential adverse event following administration of the Pfizer mRNA vaccine for COVID-19. The patient experienced persistent symptoms including diarrhea, abdominal pain, and nausea for 3 months after receiving the second dose, but showed improvement after 113 days. The report also identified additional cases of microscopic colitis in the Vaccine Adverse Event Reporting System, suggesting that providers should consider this condition as a possible diagnosis for patients with severe, persistent diarrhea after the SARS-CoV2 mRNA vaccine.
AMERICAN JOURNAL OF GASTROENTEROLOGY
(2022)
Article
Multidisciplinary Sciences
Won Ho Yang, Julia S. Westman, Douglas M. Heithoff, Markus Sperandio, Jin Won Cho, Michael J. Mahan, Jamey D. Marth
Summary: Intestinal inflammation is the underlying cause of colitis and inflammatory bowel diseases, influenced by genetic and environmental factors. Alteration in neuraminidase activity may trigger disease onset, and inhibition of Neu3 can protect against severe colitis development.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2021)
Article
Biochemistry & Molecular Biology
Sergio Lopez-Estevez, Monica Aguilera, Georgia Gris, Beatriz de la Puente, Alicia Carceller, Vicente Martinez
Summary: This study found that sigma 1Rs are involved in the development of acute colitis and its associated hypersensitivity. Selective modulation of sensory-related pathways within the colon and spinal cord may be part of the underlying mechanism.
Article
Gastroenterology & Hepatology
Sergio Lopez-Estevez, Josep Manuel Lopez-Torrellardona, Marc Parera, Vicente Martinez
Summary: This study explores the validity of DSS-induced colitis in rats as a model to mimic chronic intestinal hypersensitivity. The results indicate that DSS-induced colitis can generate a long-lasting state of visceral hypersensitivity and reproduce the changes in intestinal sensitivity characteristics of inflammatory and functional gastrointestinal disorders in humans. This research is of great importance for the development of new pharmacological treatments against visceral pain.
NEUROGASTROENTEROLOGY AND MOTILITY
(2022)
Review
Immunology
Jesse Santos, Daniel R. Calabrese, John R. Greenland
Summary: Lung transplant is a crucial therapeutic option for patients with end stage lung disease, but faces challenges such as airway inflammation and rejection reactions. Research indicates that lymphocytic airway inflammation plays a significant role in these important clinical syndromes, enhancing our understanding of post-transplant conditions.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Immunology
Niki Daferera, Sofia Nystrom, Henrik Hjortswang, Simone Ignatova, Maria C. Jenmalm, Magnus Strom, Andreas Munch
Summary: This study found that patients with collagenous colitis have lower percentages of circulating MAIT and NK cells, but no change in these cells in the colonic mucosa. Budesonide treatment does not affect the numbers of mucosal immune cells. In budesonide refractory CC, the numbers of MAIT cells, CD4(+) and CD8(+) T cells are increased.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Gastroenterology & Hepatology
Ingunn Bakke, Gunnar Andreas Walaas, Torunn Bruland, Elin Synnove Royset, Atle van Beelen Granlund, Celia Escudero-Hernandez, Silje Thorsvik, Andreas Munch, Arne Kristian Sandvik, Ann Elisabet Ostvik
Summary: NGAL/LCN2 expression is increased in the epithelium of active CC and reduced during budesonide-induced clinical remission, reaching levels similar to healthy controls and IBS-D. NGAL is proposed as an IHC marker for disease activity in CC and a potential faecal biomarker to differentiate CC from healthy controls and IBS-D.
JOURNAL OF GASTROENTEROLOGY
(2021)
Letter
Clinical Neurology
Alessandro F. Fois, Rod Conrad, Toni Hampe
Summary: Chronic diarrhea in patients with Parkinson's disease may be caused by drug-induced microscopic colitis and should be considered as a potential cause.
PARKINSONISM & RELATED DISORDERS
(2021)
Review
Gastroenterology & Hepatology
Yi-Hui Liu, Zhen Wu, Ji-Yuan Ding, Yu-Dan Shi
Summary: The study found that patients with microscopic colitis (MC) have a lower risk of colorectal adenoma or cancer compared to those without MC, supporting the recommendation that surveillance colonoscopy program is not necessary for MC patients.
INFLAMMATORY BOWEL DISEASES
(2022)
Letter
Gastroenterology & Hepatology
Conchubhair Winters, Alexander Charles Ford
Review
Gastroenterology & Hepatology
Brigida Barberio, Pierfrancesco Visaggi, Edoardo Savarino, Nicola de Bortoli, Christopher J. Black, Alexander C. Ford
Summary: This study conducted a network meta-analysis to evaluate the efficacy and safety of different medical therapies for endoscopy-negative reflux disease. The results showed that proton pump inhibitors (PPIs) are superior to other drugs in treating this condition. Future research should focus on better patient classification and investigating the efficacy of other drugs.
NEUROGASTROENTEROLOGY AND MOTILITY
(2023)
Article
Gastroenterology & Hepatology
Vivek C. Goodoory, Cho Ee Ng, Christopher J. Black, Alexander C. Ford
Summary: This study examined willingness to pay for medications among individuals with irritable bowel syndrome (IBS). The results showed that women and individuals with an annual income of 30,000 pounds or more were more likely to be willing to pay for medication. In addition, individuals with lower IBS-related quality of life were more willing to pay for a medication that could improve their symptoms.
NEUROGASTROENTEROLOGY AND MOTILITY
(2023)
Review
Gastroenterology & Hepatology
Shahida Din, Christian P. Selinger, Christopher J. Black, Alexander C. Ford
Summary: A network meta-analysis was conducted to examine the risk of Herpes zoster infection associated with biologics and small molecules used to treat inflammatory bowel disease (IBD). The results showed that Janus kinase inhibitors, particularly tofacitinib, were most likely to increase the risk of Herpes zoster infection, and the risk increased with higher doses.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2023)
Article
Gastroenterology & Hepatology
Vivek C. C. Goodoory, Elspeth A. A. Guthrie, Cho E. E. Ng, Christopher J. J. Black, Alexander C. C. Ford
Summary: Irritable bowel syndrome (IBS) has a substantial impact on the quality of life of affected individuals, and the negative impact is worse than observed in some severe chronic organic conditions.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2023)
Review
Gastroenterology & Hepatology
Maria Rosa Ingrosso, Michael Camilleri, Jan Tack, Gianluca Ianiro, Christopher J. Black, Alexander C. Ford
Summary: This study evaluated the efficacy and safety of drugs for gastroparesis through a network meta-analysis. The results showed that oral dopamine antagonists and tachykinin-1 antagonists were more effective than placebo. For individual symptoms, oral metoclopramide showed good efficacy for nausea, fullness, and bloating. However, the confidence in the evidence for most comparisons was low to moderate, indicating a need for more effective therapies for gastroparesis.
Article
Gastroenterology & Hepatology
Brigida Barberio, David J. Gracie, Christopher J. Black, Alexander C. Ford
Summary: In this study, the authors conducted a systematic review and meta-analysis to evaluate the impact of criteria used to define CD activity at study entry and the time point used to confirm efficacy on the therapeutic gain of active drug over placebo. The results showed that both factors appeared to be important in maximizing the treatment effect of active drug compared to placebo.
INFLAMMATORY BOWEL DISEASES
(2023)
Editorial Material
Gastroenterology & Hepatology
Vivek C. Goodoory, Elspeth A. Guthrie, Cho Ee Ng, Christopher J. Black, Alexander C. Ford
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2023)
Article
Gastroenterology & Hepatology
Vivek C. Goodoory, Cho E. Ng, Christopher J. Black, Alexander C. Ford
Summary: This study compared the characteristics of individuals with irritable bowel syndrome (IBS) reporting faecal incontinence (FI) with those who do not report FI. The results showed that individuals with FI were older, more likely to have IBS-D, had lower education levels and incomes, reported more urgency and more severe IBS and psychological symptoms, had lower quality of life scores, and higher healthcare costs.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2023)
Article
Gastroenterology & Hepatology
Kee-Huat Chuah, Christopher J. Black, Vincent Tee, Sze-Zee Lim, Wen-Xuan Hian, Nur-Fazimah Sahran, Yeong-Yeh Lee, Sanjiv Mahadeva, Alexander C. Ford
Summary: By comparing IBS patients from the UK and Malaysia, it was found that UK patients were more likely to consume alcohol, had more frequent symptoms such as pain, bloating, and meal-related issues, higher symptom scores, greater limitation of activities, and a higher likelihood of reporting abnormal anxiety. UK patients also had higher levels of perceived stress, gastrointestinal symptom-specific anxiety, and somatoform symptom-reporting.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2023)
Editorial Material
Gastroenterology & Hepatology
Vivek C. Goodoory, Cho Ee Ng, Christopher J. Black, Alexander C. Ford
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2023)
Editorial Material
Gastroenterology & Hepatology
David Gunn, Alexander Ford, Amanda Farrin, Robin Spiller
Summary: This article is related to the papers by Gunn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2023)
Letter
Gastroenterology & Hepatology
Vivek C. Goodoory, Elspeth A. Guthrie, Cho Ee Ng, Christopher J. Black, Alexander C. Ford
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2023)
Letter
Gastroenterology & Hepatology
Vivek C. Goodoory, Cho E. Ng, Christopher J. Black, Alexander C. Ford
Summary: This article is associated with Goodoory et al papers. Click the link to access these articles.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2023)
Letter
Gastroenterology & Hepatology
Alexander C. Ford, Colin W. Howden
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
(2023)